These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 9472836

  • 21. [SSRI antidepressants and negative schizophrenic symptoms: differences between paroxetine and fluvoxamine in patients treated with olanzapine].
    Rusconi AC, Carlone C, Muscillo M, Coccanari de' Fornari MA, Podda L, Piccione M.
    Riv Psichiatr; 2009; 44(5):313-9. PubMed ID: 20066819
    [Abstract] [Full Text] [Related]

  • 22. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
    Grimsley SR, Jann MW.
    Clin Pharm; 1992 Nov; 11(11):930-57. PubMed ID: 1464219
    [Abstract] [Full Text] [Related]

  • 23. Effect of fluvoxamine augmentation and smoking on clozapine serum concentrations.
    Augustin M, Schoretsanitis G, Pfeifer P, Gründer G, Liebe C, Paulzen M.
    Schizophr Res; 2019 Aug; 210():143-148. PubMed ID: 31182321
    [Abstract] [Full Text] [Related]

  • 24. Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data.
    Szegedi A, Wetzel H, Leal M, Härtter S, Hiemke C.
    J Clin Psychiatry; 1996 Jun; 57(6):257-64. PubMed ID: 8666564
    [Abstract] [Full Text] [Related]

  • 25. [Serious drug interaction between clozapine-Leponex and fluvoxamine-Fevarin].
    Olesen OV, Starup G, Linnet K.
    Ugeskr Laeger; 1996 Nov 25; 158(48):6931-2. PubMed ID: 8984760
    [Abstract] [Full Text] [Related]

  • 26. Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia.
    Raaska K, Raitasuo V, Neuvonen PJ.
    Eur J Clin Pharmacol; 2001 Dec 25; 57(10):705-8. PubMed ID: 11829199
    [Abstract] [Full Text] [Related]

  • 27. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH, Goa KL.
    CNS Drugs; 1997 Aug 25; 8(2):163-88. PubMed ID: 23338224
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia.
    Guitton C, Abbar M, Kinowski JM, Chabrand P, Bressolle F.
    J Clin Psychopharmacol; 1998 Dec 25; 18(6):470-6. PubMed ID: 9864080
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Fluvoxamine-Clozapine drug interaction: inhibition in vitro of five cytochrome P450 isoforms involved in clozapine metabolism.
    Olesen OV, Linnet K.
    J Clin Psychopharmacol; 2000 Feb 25; 20(1):35-42. PubMed ID: 10653206
    [Abstract] [Full Text] [Related]

  • 34. Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers.
    Saruwatari J, Yasui-Furukori N, Niioka T, Akamine Y, Takashima A, Kaneko S, Uno T.
    J Clin Psychopharmacol; 2012 Apr 25; 32(2):195-9. PubMed ID: 22367658
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia.
    Yasui-Furukori N, Kondo T, Mihara K, Inoue Y, Kaneko S.
    Psychopharmacology (Berl); 2004 Jan 25; 171(2):223-7. PubMed ID: 12955290
    [Abstract] [Full Text] [Related]

  • 37. Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.
    Jeppesen U, Gram LF, Vistisen K, Loft S, Poulsen HE, Brøsen K.
    Eur J Clin Pharmacol; 1996 Jan 25; 51(1):73-8. PubMed ID: 8880055
    [Abstract] [Full Text] [Related]

  • 38. In-vitro and in-vivo evaluation of the drug-drug interaction between fluvoxamine and clozapine.
    Chang WH, Augustin B, Lane HY, ZumBrunnen T, Liu HC, Kazmi Y, Jann MW.
    Psychopharmacology (Berl); 1999 Jul 25; 145(1):91-8. PubMed ID: 10445377
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.
    Kiev A, Feiger A.
    J Clin Psychiatry; 1997 Apr 25; 58(4):146-52. PubMed ID: 9164424
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.